Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Feasibility Study to Evaluate the Safety and Efficacy of PAK HD in ESRD Patients

NCT06433193 is registered in ClinicalTrials.gov with Nextkidney S.A. as lead sponsor.

NCT NCT06433193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06433193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Feasibility Study to Evaluate the Safety and Efficacy of PAK HD in ESRD Patients
Lead sponsor
Nextkidney S.A.
Phase
Not applicable
Overall status
Completed
Start date
February 22, 2024
Completion date
April 24, 2024
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease, esrd